Search clinical trials for: trastuzumab-MCC-DM1
Total 3257 results
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu PositiveUnited States
-
Genentech, Inc.Completed
-
Northwestern UniversityNational Cancer Institute (NCI); NovartisCompletedBYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
Genentech, Inc.Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBone Metastases | Lung Metastases | HER2-positive Breast Cancer | Liver Metastases | Stage IV Breast Cancer | Recurrent Breast Cancer | Soft Tissue MetastasesUnited States
-
University of MiamiGenentech, Inc.TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
George W. Sledge Jr.National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2 Positive Breast Carcinoma | Stage III Breast CancerUnited States
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
NRG OncologyNational Cancer Institute (NCI)RecruitingRecurrent Salivary Gland Carcinoma | Stage III Major Salivary Gland Cancer AJCC v8 | Stage IV Major Salivary Gland Cancer AJCC v8 | Metastatic Salivary Gland Carcinoma | Unresectable Salivary Gland CarcinomaUnited States
-
Genentech, Inc.Completed
-
Genentech, Inc.No longer availableMetastatic Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerFrance, Italy, Spain, Hong Kong, United States, Canada, Mexico, Denmark, Germany, Portugal, Taiwan, Switzerland, Bulgaria, Korea, Republic of, Singapore, United Kingdom, Slovenia, Bosnia and Herzegovina, Russian Federation, Br... and more
-
M.D. Anderson Cancer CenterGenentech, Inc.; Seagen Inc.RecruitingMetastatic Solid Tumor | Brain MetastasesUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage IIA Breast Cancer AJCC v8 | Prognostic Stage IIB Breast Cancer... and other conditionsUnited States, Puerto Rico
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
Daiichi SankyoAstraZeneca; Daiichi Sankyo Co., Ltd.Active, not recruitingBreast CancerUnited States, Canada, Spain, Belgium, China, Italy, Korea, Republic of, Taiwan, Australia, Japan, Brazil, France, Germany, United Kingdom, Hong Kong
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Meiji Seika Pharma Co., Ltd.Dong-A PharmaceuticalCompleted
-
West German Study GroupRoche Pharma AGActive, not recruiting
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingIntimate Partner ViolenceUnited States
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Spectrum Pharmaceuticals, IncTerminatedBreast CancerUnited States
-
Jenny C. Chang, MDGenentech, Inc.; The Methodist Hospital Research InstituteWithdrawnBreast CancerUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCActive, not recruiting
-
PfizerCompleted
-
Sahlgrenska University Hospital, SwedenSuspendedDiabetes Mellitus, Kidney, CPBSweden
-
Jules Bordet InstituteWithdrawnMetastatic HER2-positive Breast Cancer With Brain Metastasis
-
Hoffmann-La RocheCompletedBreast CancerItaly, Belgium, Canada, United Kingdom, Argentina, Australia, Austria, Brazil, Bulgaria, China, Croatia, Denmark, Dominican Republic, Ecuador, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Indonesia, Irelan... and more
-
Hoffmann-La RocheCompletedBreast CancerSpain, United States, France, Germany, Belgium, Korea, Republic of, Italy, Russian Federation
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Brain Cancer | Brain MetastasisUnited States
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast CancerUnited States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
xuexin heRecruitingHER2-positive Breast Cancer | Brain MetastasesChina
-
Hoffmann-La RocheCompletedBreast CancerSpain, France, United States, United Kingdom
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationUnited States, Spain, Korea, Republic of, Taiwan, Italy, Australia, France
-
Swiss Group for Clinical Cancer ResearchCompletedMetastatic Breast CancerFrance, Switzerland, Netherlands, Germany
-
Dana-Farber Cancer InstituteGenentech, Inc.Recruiting
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
The First Affiliated Hospital with Nanjing Medical...RecruitingAdvanced Breast Cancer | Objective Response Rate | Trastuzumab EmtansineChina
-
Hoffmann-La RocheRecruiting
-
Hoffmann-La RocheTerminatedBreast Cancer | Gastric CancerItaly, Argentina, Canada, France, Greece, Portugal, Slovakia, Brazil, Russian Federation, Spain, Germany, Serbia
-
Hoffmann-La RocheCompletedBreast CancerBelgium, Israel, Spain, Sweden, United States, Switzerland, Russian Federation, Czech Republic, France, Canada, Germany, Korea, Republic of, Australia, Hungary, Thailand, United Kingdom, Italy, Brazil, Slovakia, Poland, India, Norway